Nevertheless, a more recent network meta-analysis, encompassing 25 randomized clinical trials with a collective 1263 participants afflicted by cirrhosis and hepatorenal syndrome while evaluating 12 distinct interventions, has proposed the consideration of noradrenaline in conjunction with albumin as a potential alternative to terlipressin and albumin in forthcoming trials [51]. This evidence concerns the gene ALB and liver disorder.